IOVS Am. J. Clin. Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-1897 on August 1, 2008
(Investigative Ophthalmology and Visual Science. 2008;49:4850-4857.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.08-1897

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-1897v1
49/11/4850    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kondo, Y.
Right arrow Articles by Nishida, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kondo, Y.
Right arrow Articles by Nishida, T.

Inhibition by a Selective I{kappa}B Kinase-2 Inhibitor of Interleukin-1–Induced Collagen Degradation by Corneal Fibroblasts in Three-Dimensional Culture

Yukiko Kondo, Ken Fukuda, Tadafumi Adachi, and Teruo Nishida

From the Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Ube City, Yamaguchi, Japan.

PURPOSE. Corneal ulcer results from excessive collagen degradation in the corneal stroma. Interleukin (IL)-1 promotes this process by activating signaling molecules that include nuclear factor (NF)-{kappa}B and stimulating the synthesis of matrix metalloproteinases (MMPs) in corneal fibroblasts. NF-{kappa}B activation is mediated by phosphorylation of the inhibitor I{kappa}B by I{kappa}B kinase (IKK)-2 and consequent I{kappa}B degradation. The authors investigated the effects of the IKK-2 inhibitor [5-(p-fluorophenyl)-2-ureido]thiophene-3-carboxamide (TPCA-1) on collagen degradation by corneal fibroblasts.

METHODS. Rabbit corneal fibroblasts were cultured in three-dimensional collagen gels. Collagen degradation was evaluated by spectrophotometric quantitation of hydroxyproline in culture supernatants subjected to acid-heat hydrolysis. Expression of MMPs was evaluated by immunoblot analysis, gelatin zymography, and real-time reverse transcription polymerase chain reaction analysis. The phosphorylation and degradation of I{kappa}B{alpha} and the subcellular localization of NF-{kappa}B were examined by immunoblot and immunofluorescence analyses, respectively.

RESULTS. IL-1β–induced collagen degradation by corneal fibroblasts was inhibited by TPCA-1 in a concentration- and time-dependent manner. TPCA-1 inhibited the IL-1β–induced expression of MMP-1, -3, and -9 in these cells at both the mRNA and protein levels and the IL-1β–induced activation of pro-MMP-2. In contrast to dexamethasone, TPCA-1 inhibited the phosphorylation and degradation of I{kappa}B{alpha} and the nuclear translocation of NF-{kappa}B induced by IL-1β.

CONCLUSIONS. An IKK-2 inhibitor blocked IL-1β–induced collagen degradation by corneal fibroblasts by inhibiting the activation of the NF-{kappa}B signaling pathway and the upregulation of MMPs. IKK-2 inhibitors are thus potential alternatives to dexamethasone for the treatment of corneal ulcer.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology